Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891263 · ClinicalTrials.gov registry record · NA
Suture-based, Minimally Invasive Technique Used to Correct NSD
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04891263: Clinical Trial NA study, sponsored by Stanford University.
NCT04891263 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04891263, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Nasal Septal Deviation (NSD) is one of the most common indications for surgery seen by ENT physicians, however, correction requires open surgery which is associated with several weeks of recovery. The purpose of this study is to elucidate whether a suture-based, minimally invasive technique can be used to safely and effectively address NSD.
Primary Outcome
Unabbreviated scale title: Nasal Obstruction Symptom Evaluation. Mean change from baseline. Minimum value = 0, maximum value = 100. Higher score indicates a worse outcome.
Interventions
- PROCEDURE Suture-Septoplasty
- DEVICE Surgical suture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-08-02 |
| Est. Completion | 2021-09-13 |
| Phase | NA |
Why NCT04891263 stopped before completion
NCT04891263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Suture-Septoplasty is the first listed.
NCT04891263 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04891263 about?
NCT04891263 is a clinical study titled "Suture-based, Minimally Invasive Technique Used to Correct NSD". Nasal Septal Deviation (NSD) is one of the most common indications for surgery seen by ENT physicians, however, correction requires open surgery which is associated with several weeks of recovery. The purpose of this study is to elucidate whether a suture-based, minimally invasive technique can be u...
What is the current status of trial NCT04891263?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2021-08-02. Estimated completion is 2021-09-13.
What interventions are being tested in trial NCT04891263?
The interventions under investigation include: Suture-Septoplasty (PROCEDURE), Surgical suture (DEVICE).
Who is sponsoring clinical trial NCT04891263?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04891263's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI